SMTL ID : 3ug8.1

AKR1C3 complex with indomethacin at pH 7.5

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.73 Å

Oligo State

monomer

Ligands

1 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NAP.1: 29 residues within 4Å: Chain A: G.22, T.23, Y.24, D.50, Y.55, K.84, H.117, S.166, N.167, Q.190, Y.216, S.217, A.218, L.219, G.220, S.221, Q.222, L.236, A.253, L.268, A.269, K.270, S.271, Y.272, N.273, R.276, Q.279, N.280 Ligands: IMN.2 30 PLIP interactions: 30 interactions with chain A Hydrophobic interactions: A:Y.216, A:Y.216, A:Y.216 Hydrogen bonds: A:T.23, A:Y.24, A:D.50, A:D.50, A:S.166, A:N.167, A:Q.190, A:S.217, A:L.219, A:S.221, A:Q.222, A:Q.222, A:Q.222, A:K.270, A:S.271, A:Y.272, A:Q.279, A:N.280 Water bridges: A:S.217, A:A.218, A:A.218, A:S.221, A:R.276, A:Q.279 Salt bridges: A:K.270, A:R.276 pi-Cation interactions: A:R.276

1 x IMN: INDOMETHACIN(Non-covalent)

IMN.2: 17 residues within 4Å: Chain A: Y.24, L.54, Y.55, W.86, H.117, M.120, N.167, E.192, Y.216, S.217, S.221, Y.305, F.306, Y.317, P.318, Y.319 Ligands: NAP.1 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:L.54, A:W.86, A:F.306, A:F.306, A:F.306, A:F.306 Hydrogen bonds: A:Y.55, A:S.217 Water bridges: A:Q.222 Salt bridges: A:H.117 pi-Stacking: A:Y.216

1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.3: 9 residues within 4Å: Chain A: Q.6, P.17, V.18, L.19, G.45, F.46, R.47, H.48, F.284 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:Q.6, A:Q.6, A:V.18, A:L.19, A:R.47, A:H.48

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Flanagan, J.U. et al., Crystal structures of three classes of non-steroidal anti-inflammatory drugs in complex with aldo-keto reductase 1C3. Plos One (2012)

Release Date

2012-08-15

Peptides

Aldo-keto reductase family 1 member C3: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Aldo-keto reductase family 1 member C3

Related Entries With Identical Sequence